First Tracks director granted 7,000 options, 2,500 RSUs
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
First Tracks Biotherapeutics director equity grants: Director John A. Orwin received stock options for 7,000 shares of Common Stock at an exercise price of $17.81 per share and 2,500 Restricted Stock Units on May 12, 2026, as compensation awards, not open‑market trades.
The 2,500 RSUs each represent one share of Common Stock for no cash cost and vest 100% on the date of the company’s 2027 annual shareholder meeting, if he continues serving the company. The 7,000 stock options vest in 12 equal monthly installments starting June 12, 2026, through full vesting, also conditioned on continued service.
Insider Trade Summary
Grant/Award: 9,500 shares
Grant/Award
2 txns
Insider
Orwin John A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 2,500 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 7,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 2,500 contracts (Direct);
Stock Option (right to buy) — 7,000 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F3. The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Stock options granted: 7,000 options
Option exercise price: $17.81 per share
Option expiration: May 11, 2036
+5 more
8 metrics
Stock options granted
7,000 options
Grant on May 12, 2026 to director John A. Orwin
Option exercise price
$17.81 per share
Exercise price for 7,000 stock options
Option expiration
May 11, 2036
Expiration date of stock options
RSUs granted
2,500 RSUs
Grant on May 12, 2026 to director John A. Orwin
RSU settlement ratio
1 share per RSU
Each RSU converts into one Common share for no consideration
RSU vesting date
2027 annual meeting date
100% of RSUs vest at 2027 shareholder meeting, subject to service
Option vesting schedule
1/12 monthly from June 12, 2026
Monthly vesting until fully vested, subject to continued service
Options held after grant
7,000 options
Total options following the reported transaction
Key Terms
Restricted Stock Unit, stock option, vests, exercise price
4 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests financial
"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders"
exercise price financial
"conversion_or_exercise_price": "17.8100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did TRAX director John A. Orwin report on May 12, 2026?
Director John A. Orwin reported receiving equity awards, not market trades. He was granted stock options for 7,000 TRAX common shares at $17.81 per share and 2,500 Restricted Stock Units, all as compensation, contingent on future service-based vesting conditions.
How many stock options did TRAX grant to director John A. Orwin and at what price?
First Tracks Biotherapeutics granted John A. Orwin stock options for 7,000 shares of Common Stock at an exercise price of $17.81 per share. These options vest monthly over 12 months beginning June 12, 2026, assuming he continues providing service to the company.
What are the key terms of John A. Orwin’s RSU grant from TRAX?
John A. Orwin received 2,500 Restricted Stock Units, each RSU representing a right to one share of TRAX Common Stock for no cash payment. The RSUs vest 100% on the date of the company’s 2027 annual shareholder meeting, contingent on his continued service through that date.
When do John A. Orwin’s TRAX stock options and RSUs vest?
The 7,000 TRAX stock options vest in 12 equal monthly installments starting June 12, 2026 until fully vested. The 2,500 RSUs vest as to 100% of the award on the date of First Tracks Biotherapeutics’ 2027 annual meeting of shareholders, subject to continued service.
Are John A. Orwin’s TRAX Form 4/A transactions open-market buys or sells?
The reported transactions are compensation awards, not open-market trades. They are coded as “A” grants, reflecting stock options and Restricted Stock Units awarded by the company. No open-market purchases or sales were reported, and transaction prices per share were shown as zero for the awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates